134 related articles for article (PubMed ID: 10541775)
1. Assessment of analgesia in human chronic pain. Randomized double-blind crossover study of once daily repro-dose morphine versus MST continus.
Peat S; Sweet P; Miah Y; Barklamb M; Larsen U
Eur J Clin Pharmacol; 1999 Oct; 55(8):577-81. PubMed ID: 10541775
[TBL] [Abstract][Full Text] [Related]
2. A randomized crossover study comparing the efficacy and tolerability of a novel once-daily morphine preparation (MXL capsules) with MST Continus tablets in cancer patients with severe pain.
O'Brien T; Mortimer PG; McDonald CJ; Miller AJ
Palliat Med; 1997 Nov; 11(6):475-82. PubMed ID: 9519171
[TBL] [Abstract][Full Text] [Related]
3. A randomized, double-blind, multi-site, crossover, placebo-controlled equivalence study of morning versus evening once-daily sustained-release morphine sulfate in people with pain from advanced cancer.
Currow DC; Plummer JL; Cooney NJ; Gorman D; Glare PA
J Pain Symptom Manage; 2007 Jul; 34(1):17-23. PubMed ID: 17601560
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of twenty-four-hourly Kapanol compared to twelve-hourly MS Contin in the treatment of severe cancer pain.
Gourlay GK; Cherry DA; Onley MM; Tordoff SG; Conn DA; Hood GM; Plummer JL
Pain; 1997 Feb; 69(3):295-302. PubMed ID: 9085304
[TBL] [Abstract][Full Text] [Related]
5. Patient-controlled analgesia for mucositis pain in children: a three-period crossover study comparing morphine and hydromorphone.
Collins JJ; Geake J; Grier HE; Houck CS; Thaler HT; Weinstein HJ; Twum-Danso NY; Berde CB
J Pediatr; 1996 Nov; 129(5):722-8. PubMed ID: 8917240
[TBL] [Abstract][Full Text] [Related]
6. Oral naltrexone to enhance analgesia in patients receiving continuous intrathecal morphine for chronic pain: a randomized, double-blind, prospective pilot study.
Hamann S; Sloan P
J Opioid Manag; 2007; 3(3):137-44. PubMed ID: 18027539
[TBL] [Abstract][Full Text] [Related]
7. Controlled-release oxycodone and morphine in cancer related pain.
Heiskanen T; Kalso E
Pain; 1997 Oct; 73(1):37-45. PubMed ID: 9414055
[TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, cross-over trial comparing safety and efficacy of oral controlled-release oxycodone with controlled-release morphine in patients with cancer pain.
Bruera E; Belzile M; Pituskin E; Fainsinger R; Darke A; Harsanyi Z; Babul N; Ford I
J Clin Oncol; 1998 Oct; 16(10):3222-9. PubMed ID: 9779695
[TBL] [Abstract][Full Text] [Related]
9. Efficacy, safety, and steady-state pharmacokinetics of once-a-day controlled-release morphine (MS Contin XL) in cancer pain.
Hagen NA; Thirlwell M; Eisenhoffer J; Quigley P; Harsanyi Z; Darke A
J Pain Symptom Manage; 2005 Jan; 29(1):80-90. PubMed ID: 15652441
[TBL] [Abstract][Full Text] [Related]
10. Controlled-release morphine (MST Contin) in advanced cancer. The European experience.
Hanks GW
Cancer; 1989 Jun; 63(11 Suppl):2378-82. PubMed ID: 2655869
[TBL] [Abstract][Full Text] [Related]
11. Steady-state pharmacokinetic comparison of a new, extended-release, once-daily morphine formulation, Avinza, and a twice-daily controlled-release morphine formulation in patients with chronic moderate-to-severe pain.
Portenoy RK; Sciberras A; Eliot L; Loewen G; Butler J; Devane J
J Pain Symptom Manage; 2002 Apr; 23(4):292-300. PubMed ID: 11997198
[TBL] [Abstract][Full Text] [Related]
12. A randomized, double-blind, placebo-controlled, cross-over pilot study to assess the effects of long-term opioid drug consumption and subsequent abstinence in chronic noncancer pain patients receiving controlled-release morphine.
Cowan DT; Wilson-Barnett J; Griffiths P; Vaughan DJ; Gondhia A; Allan LG
Pain Med; 2005; 6(2):113-21. PubMed ID: 15773875
[TBL] [Abstract][Full Text] [Related]
13. Buprenorphine transdermal delivery system in adults with persistent noncancer-related pain syndromes who require opioid therapy: a multicenter, 5-week run-in and randomized, double-blind maintenance-of-analgesia study.
Landau CJ; Carr WD; Razzetti AJ; Sessler NE; Munera C; Ripa SR
Clin Ther; 2007 Oct; 29(10):2179-93. PubMed ID: 18042474
[TBL] [Abstract][Full Text] [Related]
14. Fentanyl buccal tablet for the relief of breakthrough pain in opioid-tolerant adult patients with chronic neuropathic pain: a multicenter, randomized, double-blind, placebo-controlled study.
Simpson DM; Messina J; Xie F; Hale M
Clin Ther; 2007 Apr; 29(4):588-601. PubMed ID: 17617282
[TBL] [Abstract][Full Text] [Related]
15. Double-blind evaluation of transdermal nitroglycerine as adjuvant to oral morphine for cancer pain management.
Lauretti GR; Perez MV; Reis MP; Pereira NL
J Clin Anesth; 2002 Mar; 14(2):83-6. PubMed ID: 11943517
[TBL] [Abstract][Full Text] [Related]
16. Randomised trial of oral morphine for chronic non-cancer pain.
Moulin DE; Iezzi A; Amireh R; Sharpe WK; Boyd D; Merskey H
Lancet; 1996 Jan; 347(8995):143-7. PubMed ID: 8544547
[TBL] [Abstract][Full Text] [Related]
17. A randomized, double-blind, 8-week crossover study of once-daily controlled-release tramadol versus immediate-release tramadol taken as needed for chronic noncancer pain.
Beaulieu AD; Peloso P; Bensen W; Clark AJ; Watson CP; Gardner-Nix J; Thomson G; Piraino PS; Eisenhoffer J; Harsanyi Z; Darke AC
Clin Ther; 2007 Jan; 29(1):49-60. PubMed ID: 17379046
[TBL] [Abstract][Full Text] [Related]
18. A comparison of regularly administered sustained release oral morphine with intramuscular morphine for control of postoperative pain.
Bourke M; Hayes A; Doyle M; McCarroll M
Anesth Analg; 2000 Feb; 90(2):427-30. PubMed ID: 10648333
[TBL] [Abstract][Full Text] [Related]
19. Twice-daily versus once-daily morphine sulphate controlled-release suppositories for the treatment of cancer pain. A randomized controlled trial.
Bruera E; Belzile M; Neumann CM; Ford I; Harsanyi Z; Darke A
Support Care Cancer; 1999 Jul; 7(4):280-3. PubMed ID: 10423055
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of a cancer pain model for the testing of long-acting analgesics. The effect of MS Contin in a double-blind, randomized crossover design.
Cundiff D; McCarthy K; Savarese JJ; Kaiko R; Thomas G; Grandy R; Goldenheim P
Cancer; 1989 Jun; 63(11 Suppl):2355-9. PubMed ID: 2720581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
